Diagnosis: Squamous cell carcinoma in situ (Bowen disease)
A 68-year-old male presents with a gradually enlarging erythematous scaly patch on the right leg, which has persisted for several months. The lesion is located on sun-damaged skin, exhibiting features consistent with a malignancy that warrants further investigation and management.
A 68-year-old male with a history of extensive sun exposure presents with a slowly enlarging erythematous scaly patch on his right lower leg, present for 6 months. On examination, the lesion measures approximately 3 cm, with an irregular border and adherent scale. The patient reports mild itching but no pain or bleeding.Location: Right lower leg, sun-exposed area.Size: Approximately 3 cm in diameter.Border: Irregular with a well-defined margin.Surface: Erythematous with adherent scale.Symptoms: Mild itching, no pain or bleeding.
The lesion began as a small, asymptomatic patch that gradually enlarged over the past 6 months. The patient has a significant history of chronic sun exposure due to outdoor hobbies. He has not attempted any treatments for this lesion. His past medical history includes actinic keratosis and non-melanoma skin cancers, with no family history of skin cancer. Social history is notable for a long-term smoking habit.Onset: Lesion noted 6 months ago.Triggers: Extensive sun exposure.Prior treatments: None attempted for this lesion.Medical history: Actinic keratosis and non-melanoma skin cancers.Family history: No skin cancer.Social history: Long-term smoker.
Acute / First-Line ManagementTopical 5-fluorouracil: Apply twice daily for 3-4 weeks to induce an inflammatory response in the lesion.Imiquimod cream: Apply 5 times a week for 16 weeks as an alternative to 5-FU.Photodynamic therapy: Consider for superficial lesions, utilizing aminolevulinic acid followed by blue light exposure.Workup and Diagnostic ConfirmationBiopsy: Full-thickness skin biopsy is essential for diagnosis, confirming the presence of atypical keratinocytes.Dermatoscopy: Can assist in visualizing vascular patterns and surface characteristics indicative of malignancy.Long-Term ManagementRegular skin checks: Recommend follow-up every 6-12 months for skin surveillance.Sun protection: Advise daily broad-spectrum sunscreen and protective clothing.Address risk factors: Discuss cessation of smoking to improve overall skin health.
Actinic keratosis: Common precursor lesions characterized by rough, scaly patches that may be tender. Typically occur on sun-damaged skin.Basal cell carcinoma: Often presents as a pearly papule or non-healing sore, usually with telangiectasia. Less likely to be scaly compared to the index lesion.Psoriasis: Presents with well-defined, erythematous plaques with silvery scales, often with a family history and may involve other body areas.Seborrheic keratosis: Benign lesions that appear as stuck-on plaques, typically with a waxy surface and less scaling than the index lesion.Lichen planus: Can appear as purple, polygonal papules with Wickham striae, often pruritic, affecting flexural surfaces.Keratoacanthoma: Rapidly growing lesion that may resemble squamous cell carcinoma but typically has a central keratin-filled crater.Paget's disease of the skin: Rare, characterized by a red, scaly patch, usually affecting the nipple area, and may be associated with underlying malignancies.Granuloma annulare: Presents as annular plaques with a smooth surface, typically asymptomatic and self-limiting, more common in younger populations.
High-Yield PearlsSun exposure: Chronic sun exposure is a significant risk factor for developing skin cancers, including in situ lesions.Biopsy importance: A full-thickness biopsy is essential for confirming the diagnosis of atypical keratinocytes.Topical therapies: First-line treatments include 5-fluorouracil and imiquimod, both effective in managing superficial malignancies.Regular surveillance: Patients with a history of non-melanoma skin cancers should undergo regular dermatological evaluations.Prevention: Daily sun protection, including sunscreen and protective clothing, is crucial in preventing further skin damage and malignancies.Early recognition and management of atypical keratinocytes can prevent progression to invasive squamous cell carcinoma.
Tags: SCC, Bowen, in situ